COVID-19

Business & Regulation Business Practice

08/25/2023 | Stephanie Sutton | 3 min read

The pharma giant’s COVID-19 vaccine saved millions of lives, but the company is quickly falling from grace.

Discovery & Development Advanced Medicine

08/04/2023 | Stephanie Sutton

We interviewed Gamma Biosciences’s CTO Phil Vanek to learn more about the current state of the Cell and Gene Industry

Discovery & Development Advanced Medicine

07/24/2023 | Stephanie Sutton

Check out our latest video interview with Angela Osborne who discusses the latest cell and gene industry trends.

Discovery & Development Formulation

05/15/2023 | Jamie Irvine | 2 min read

Modified screening process optimizes nanobodies for sustainable COVID-19 treatments derived from llamas.

Discovery & Development Formulation

04/19/2023 | Jamie Irvine | 2 min read

Researchers use genome mining and bioengineering techniques to develop sustainable saponin-based vaccine adjuvants

Discovery & Development Formulation

03/20/2023 | Joseph Payne | 8 min read

Why is self-amplifying mRNA gaining more and more attention in the vaccine space?

Business & Regulation Business Practice

03/06/2023 | Rainer Lichtenberger | 8 min read

What are the lessons we must learn from the COVID-19 pandemic?

Business & Regulation COVID-19

01/18/2023 | Stephanie Sutton | 3 min read

Anti-vaccine activists are suing a number of prominent media outlets, including Reuters, the Washington Post, the BBC, and the Associated Press.

Business & Regulation Trends & Forecasts

01/10/2023 | Angus Stewart | 6 min read

In the face of war and the economic fallout of COVID-19, Europe is weathering an energy price storm. What does this mean for medicine makers?

Business & Regulation Marketing

12/20/2022 | Rob Coker | 4 min read

For any organization, one ill-timed tweet can create enormous backlash.